Ascendo Biotechnology Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Our pipeline is driven by our revolutionary research into immune response. Each product builds on our unique understanding of innate immunity and how this natural control can be used to destroy solid tumors or calm autoimmune inflammation. ASD141, our fir
Founded Year
2023
Unified Business No.
83000625
Status
Active
Number of Employees
0
Total Paid-in
Capital
242,420,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Ascendo Biotechnology is a clinical-stage pharmaceutical company founded in 2019. We leverage cutting-edge research in the field of dysregulated immune function to develop novel immunotherapy solutions for cancer and autoimmune diseases.
